What we do
Public consultation on the EIB Group's Environmental and Social Sustainability Framework - informational webinars
Public consultation on the EIB Group's Environmental and Social Sustainability Framework
The EIF in 2020
Coronavirus: The EIB Group’s initiatives to address its economic consequences
Pan-European Guarantee Fund – EGF
Sustainable Development Umbrella Fund
SDUF Health Compartment
Equity products
AI Co-Investment Facility
Climate & Infrastructure Funds
Technology Transfer
European Angels Fund (EAF) - Co-investments with Business Angels
Venture capital
The Social Impact Accelerator (SIA)
Lower mid-market
Mezzanine Facility for Growth
VentureEU
EFSI Equity instrument
Single EU Equity Financial Instrument
COSME - Equity Facility for Growth
InnovFin Equity
Private equity secondary market transactions
EIF-NPI Equity Platform
ESCALAR Programme
Debt products
New ESIF ERDF Guarantee Fund initiative in Greece
EFSI Private Credit Programme
AGRI Guarantee Facility
AGRI Italy Platform Uncapped Guarantee Instrument
Credit enhancement
Cultural and Creative Sectors Guarantee Facility (CCS GF)
ENSI - Securitisation Initiative
Erasmus+ Master Loan Guarantee Facility
Skills & Education Guarantee Pilot
EREM debt products
Single EU Debt Financial Instrument
InnovFin SME Guarantee Facility
COSME - Loan Guarantee Facility
Documentary Finance Facility – Bulgaria
The SME Initiative
The SME Initiative Bulgaria
The SME Initiative Finland
The SME Initiative Italy
The SME Initiative Malta
The SME Initiative Romania
The SME Initiative Spain
Inclusive finance
EaSI Financial Instruments
EaSI Capacity Building Investments Window
EaSI Guarantee Instrument
EaSI Funded Instrument
European Progress Microfinance Facility
Entrepreneurs supported through Progress Microfinance
European Fund for Strategic Investments (EFSI)
How does EIF contribute to EFSI
How to apply for EFSI financing
Regional Development - Country and sector-specific initiatives
Prêt Participatif Grand Est
Dutch Future Fund (DFF)
Dutch Alternative Credit Instrument (DACI)
PORTUGAL BLUE: a new initiative for blue economy investments
JEREMIE Greece Reflows – Business Angels’ Co-Investment Equity Instrument
German Corona Matching Facility (CMF)
Portugal Growth programme
Croatian Growth Investment Programme (CROGIP)
Central and Eastern European Technology Transfer (CEETT)
AGRI Italy Platform Uncapped Guarantee Instrument
ALTER’NA – ESIF EARFD Nouvelle-Aquitaine
Baltic Innovation Fund 1 (BIF 1)
Baltic Innovation Fund 2 (BIF 2)
Central Europe Fund of Funds (CEFoF)
Croatian Venture Capital Initiative (CVCi FoF)
Competitiveness Fund-of-Funds for SMEs in Romania
The Cyprus Entrepreneurship Fund (CYPEF)
Deep and Comprehensive Free Trade Area Initiative East Guarantee Facility (DCFTA)
Dutch Growth Co-Investment Programme
Dutch Venture Initiative (DVI-II)
ESIF Fund-of-Funds Greece
EAFRD FoF Portugal
EAFRD FoF Romania
The ERP-EIF Facility
ERP-EIF Co-Investment Growth Facility
The LfA-EIF Facilities
The German Future Fund (GFF) - EIF Growth Facility
INAF – French National Agricultural Initiative
ESIF Energy Efficiency and Renewable Energy Malta
Regional Fund-of-Funds Romania
ESIF Fund-of-Funds Czech Republic
The Silesia EIF Fund of Funds
La Financière Région Réunion
The EIB Group Risk Enhancement Mandate (EREM)
EstFund
FOSTER TPE-PME Occitanie
Greater Anatolia Guarantee Facility (GAGF)
G43 - Anatolian Venture Capital Fund Project
InvestBG Equity Instrument
JEREMIE
JEREMIE Romania Reflows – Equity Instrument
Luxembourg Future Fund (LFF)
Mezzanine 'Fund of Fund' for Germany (MDD)
Polish Growth Fund of Funds (PGFF)
Portugal Venture Capital Initiative (PVCi)
Scottish-European Growth Co-Investment Programme
Slovene Equity Growth Investment Programme (SEGIP)
Swedish Venture Initiative (SVI)
Turkish Growth and Innovation Fund (TGIF)
Western Balkans Enterprise Development & Innovation Facility (WB EDIF)
EAFRD FoF Greece

Umana Medical Technologies: unattended, wireless monitoring of the heart

image

With cardiovascular diseases being the largest single cause of death in the EU, accounting annually for about 2 million deaths, there are good reasons to ensure support for companies that are pushing the boundaries of medical technology to find better ways to protect people's health.

One new solution recently introduced to the market comes from Umana Medical Technologies, a Maltese company with proprietary technology based on the latest innovations in the fields of nanotechnology, biosensors and wearable devices.

Its flagship product, the Umana T1 Heart Monitor, functions as a non-invasive vital signs monitoring device. As Dr. Adrian Trevisan, CEO and co-founder, explains: “It’s a bit like temporary tattoos, but using a nanomaterial we developed and including sensors and transmitters to do everything that other heart monitors can do, only without the nuisance.”

This innovative device has very thin epidermal sensors that take measurements with more accuracy and precision than traditional, bulkier equipment, while holding the same quality certifications. They capture and analyse in real-time the electrical activity of the heart, and remain in place for up to five days without any inconvenience for the user.

From the sensor, data transfers wirelessly to an application running on a normal smartphone, recording and analysing signals for monitoring and detecting abnormalities. Medical professionals can access the information remotely, and whenever a significant activity is detected, the user can choose to have a text message sent immediately to a chosen third party.

In 2017, the company secured financing from the Bank of Valletta, in the form of a loan guaranteed by EIF. These funds were used to take the technology into the manufacturing stage, creating nine new jobs in the process. As Adrian notes: “This financing gave us much-needed breathing space, without which it would have been impossible to get to this stage. It allowed us to invest in the right talent to take the business to the next level.”

The company is currently taking pre-orders and developing its manufacturing facilities with the aim of hitting the market by the end of 2017. At the same time, they are also working on new applications of this technology, through devices designed to monitor muscles, the brain and even sweat. Watch this space.

Company: Umana Medical Technologies (Malta)

Type of business: Medical devices

EIF financing: SME Initiative Malta

Financial intermediary: Bank of Valletta

For further information about EIF intermediaries in Malta, please refer to: http://www.eif.org/what_we_do/where/mt/index.htm

 

We use cookies to give the best browser experience on our website. or change cookie settings.

Note: Following the recent withdrawal of the United Kingdom from the European Union, we are updating the relevant EIF.org pages.

 
 

Copyright ©

 European Investment Fund 2021 – The European Investment Fund is not responsible for the content of external internet sites.